Hepatology

Innovative liver disease treatments addressing acute and chronic hepatic conditions

Liver Disease Innovation

Oracle BioTech develops cutting-edge therapies for liver diseases including viral hepatitis, non-alcoholic fatty liver disease, cirrhosis, and hepatocellular carcinoma.

Hepatitis Research

Viral Hepatitis

Advanced antiviral therapies for hepatitis B and C with improved cure rates and shorter treatment durations.

  • Direct-acting antivirals
  • Hepatitis B cure research
  • Combination therapy regimens
  • Resistance barrier enhancement
Learn More
Liver Disease Research

NASH & Liver Fibrosis

Novel treatments for non-alcoholic steatohepatitis and liver fibrosis targeting multiple disease pathways.

  • NASH progression inhibitors
  • Anti-fibrotic agents
  • Metabolic pathway modulators
  • Liver regeneration therapy
Learn More

Hepatology Pipeline

Discovery

7 Programs

Novel liver-specific targets and mechanisms.

Preclinical

5 Programs

Liver disease models and hepatotoxicity studies.

Phase I

3 Programs

Safety studies in liver disease patients.

Phase II

2 Programs

Efficacy studies in NASH and hepatitis B.

Approved

1 Product

FDA-approved hepatitis C treatment.